Emicizumab

Definition: Emicizumab, sold under the brand name Hemlibra, is a humanized bispecific monoclonal antibody for the treatment of haemophilia A, developed by Genentech and Chugai (both organizations are subsidiaries of Hoffmann-La Roche). Emicizumab is a bispecific factor IXa- and factor X-directed antibody. In November 2017, it was approved in the United States for treatment of haemophilia A in those who had developed resistance to other treatments. source: Wikipedia

ID

763611007

ID date

7 Jan 2022

Previous ID

35101811000001106

Name

Emicizumab